These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17388998)

  • 1. Insight and danger in Alzheimer's disease.
    Starkstein SE; Jorge R; Mizrahi R; Adrian J; Robinson RG
    Eur J Neurol; 2007 Apr; 14(4):455-60. PubMed ID: 17388998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anosognosia in Alzheimer's disease: diagnosis, frequency, mechanism and clinical correlates.
    Starkstein SE
    Cortex; 2014 Dec; 61():64-73. PubMed ID: 25481465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anosognosia in Alzheimer's disease: a study of associated factors.
    Migliorelli R; Tesón A; Sabe L; Petracca G; Petracchi M; Leiguarda R; Starkstein SE
    J Neuropsychiatry Clin Neurosci; 1995; 7(3):338-44. PubMed ID: 7580194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anosognosia in patients with Alzheimer's disease: current perspectives.
    Tagai K; Nagata T; Shinagawa S; Shigeta M
    Psychogeriatrics; 2020 May; 20(3):345-352. PubMed ID: 31930617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anosognosia is a significant predictor of apathy in Alzheimer's disease.
    Starkstein SE; Brockman S; Bruce D; Petracca G
    J Neuropsychiatry Clin Neurosci; 2010; 22(4):378-83. PubMed ID: 21037121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anosognosia and depression in patients with Alzheimer's dementia.
    Verhülsdonk S; Quack R; Höft B; Lange-Asschenfeldt C; Supprian T
    Arch Gerontol Geriatr; 2013; 57(3):282-7. PubMed ID: 23597486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anosognosia in Alzheimer's disease: the role of impairment levels in assessment of insight across domains.
    Leicht H; Berwig M; Gertz HJ
    J Int Neuropsychol Soc; 2010 May; 16(3):463-73. PubMed ID: 20188013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the relation among mood, apathy, and anosognosia in Alzheimer's disease.
    Mograbi DC; Morris RG
    J Int Neuropsychol Soc; 2014 Jan; 20(1):2-7. PubMed ID: 24331082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence of anosognosia in Alzheimer's disease].
    Turró-Garriga O; Conde-Sala JL; Reñé-Ramírez R; López-Pousa S; Gascón-Bayarri J; Garre-Olmo J
    Med Clin (Barc); 2014 Jul; 143(1):13-9. PubMed ID: 23830548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A diagnostic formulation for anosognosia in Alzheimer's disease.
    Starkstein SE; Jorge R; Mizrahi R; Robinson RG
    J Neurol Neurosurg Psychiatry; 2006 Jun; 77(6):719-25. PubMed ID: 16549411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burden associated with the presence of anosognosia in Alzheimer's disease.
    Turró-Garriga O; Garre-Olmo J; Vilalta-Franch J; Conde-Sala JL; de Gracia Blanco M; López-Pousa S
    Int J Geriatr Psychiatry; 2013 Mar; 28(3):291-7. PubMed ID: 22555993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting Anosognosia from the Prodromal Stage of Alzheimer's Disease.
    Guieysse T; Lamothe R; Houot M; Razafimahatratra S; Medani T; Lejeune FX; Dreyfus G; Klarsfeld A; Pantazis D; Koechlin E; Andrade K
    J Alzheimers Dis; 2023; 95(4):1723-1733. PubMed ID: 37718816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical differences in patients with Alzheimer's disease according to the presence or absence of anosognosia: implications for perceived quality of life.
    Conde-Sala JL; Reñé-Ramírez R; Turró-Garriga O; Gascón-Bayarri J; Juncadella-Puig M; Moreno-Cordón L; Viñas-Diez V; Garre-Olmo J
    J Alzheimers Dis; 2013; 33(4):1105-16. PubMed ID: 23128559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrepancies regarding the quality of life of patients with Alzheimer's disease: a three-year longitudinal study.
    Conde-Sala JL; Turró-Garriga O; Garre-Olmo J; Vilalta-Franch J; Lopez-Pousa S
    J Alzheimers Dis; 2014; 39(3):511-25. PubMed ID: 24217273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient versus informant reported quality of life in the earliest phases of Alzheimer's disease.
    Vogel A; Mortensen EL; Hasselbalch SG; Andersen BB; Waldemar G
    Int J Geriatr Psychiatry; 2006 Dec; 21(12):1132-8. PubMed ID: 16955419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Unawareness of deficits in Alzheimer's disease: a multidimentional approach].
    Trouillet R; Gély-Nargeot MC; Derouesné C
    Psychol Neuropsychiatr Vieil; 2003 Jun; 1(2):99-110. PubMed ID: 15683946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anosognosia and procedural learning in Alzheimer's disease.
    Starkstein SE; Sabe L; Cuerva AG; Kuzis G; Leiguarda R
    Neuropsychiatry Neuropsychol Behav Neurol; 1997 Apr; 10(2):96-101. PubMed ID: 9150509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What are the neural correlates of meta-cognition and anosognosia in Alzheimer's disease? A systematic review.
    Hallam B; Chan J; Gonzalez Costafreda S; Bhome R; Huntley J
    Neurobiol Aging; 2020 Oct; 94():250-264. PubMed ID: 32679396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrieval monitoring and anosognosia in Alzheimer's disease.
    Gallo DA; Chen JM; Wiseman AL; Schacter DL; Budson AE
    Neuropsychology; 2007 Sep; 21(5):559-68. PubMed ID: 17784804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finger agnosia and cognitive deficits in patients with Alzheimer's disease.
    Davis AS; Trotter JS; Hertza J; Bell CD; Dean RS
    Appl Neuropsychol Adult; 2012; 19(2):116-20. PubMed ID: 23373578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.